Latest Equities News

Argo Investments reported a striking 79% jump in half-year profit to $130.8 million, underpinned by stronger investment income, and announced an 18.5 cents per share fully franked interim dividend.

Future Generation Global Limited has announced a substantial 49% increase in its fully franked dividend for FY2025, alongside a special dividend, reflecting robust portfolio performance and a commitment to shareholder returns.

Challenger Limited confirms advanced discussions with Pepper Group to jointly acquire Pepper Money, aiming for strategic access to fixed income assets and accretive earnings.

DGR Global has been flagged by ASX for breaching Listing Rule 10.1 after advancing $500,000 without prior shareholder approval. The company is now preparing to seek retroactive approval and address further funding tranches.

News Corporation reported a 4% revenue increase to US$4.506 billion for the half-year ended December 2025, while net income declined 9% to US$305 million. The company declared an interim dividend and continued its stock repurchase program amid mixed segment performances and ongoing legal challenges.

Shares of Apiam Animal Health Limited (ASX – AHX) have been suspended from trading following court approval of its acquisition by entities controlled by Adamantem Capital Fund II. This marks a significant ownership change for the animal health company.

Conico Ltd is set to raise $85,000 through a follow-on share placement at $0.008 per share, targeting strategic shareholders to meet excess demand from its recent entitlement offer.

Apiam Animal Health has secured court approval for its corporate scheme, paving the way for a fully franked special dividend payment next month.

Canyon Resources updates progress on its Minim Martap Bauxite Project, confirming key milestones despite locomotive delivery delays that push the maiden bauxite shipment to Q3 2026.

The Supreme Court of New South Wales has approved the scheme of arrangement for Adamantem Capital Fund II’s acquisition of Apiam Animal Health, marking a pivotal step toward the deal’s completion and the suspension of Apiam shares on the ASX.

WAM Active Limited has launched a $51.4 million pro-rata entitlement offer at a 7.8% discount to the recent share price, alongside a $19.3 million institutional placement to meet strong investor demand. The capital raising aims to bolster the company’s proven Australian equity investment strategy while offering shareholders fully franked dividends on new shares.

Terragen Holdings has raised A$7 million through a strategic equity raising to fund scientific research and accelerate global commercialisation, while appointing Dr Michele Allan AO as its new Chair.